youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
ARGX:NASDAQ
argenx SE - ADR
$825.61
arrow_upward
+0.79%(+6.47) 1D
$825.61
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$815.56
High
$828.69
Low
$814.40
Mkt. cap
51.73B
Avg. vol.
368.24K
Volume
393.10K
P/E ratio
31.37
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
Open
$815.56
High
$828.69
Low
$814.40
Mkt. cap
51.73B
Avg. vol.
368.24K
Volume
393.10K
P/E ratio
31.37
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
9 hours ago
Argenx stock: Goldman Sachs keeps EUR 959.00 target for Argenx stock
Investing.com
·
10 hours ago
argenx reports positive phase 3 results for myositis treatment
ad-hoc-news.de
·
14 hours ago
argenx sets October 22 results date for argenx stock
ad-hoc-news.de
·
17 hours ago
Argenx stock at EUR 732.70 ahead of the Xetra open today
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR